First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 1,500 shares, a growth of 275.0% from the December 15th total of 400 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is presently 0.6 days.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

Shares of FTXH stock traded down $0.31 on Tuesday, hitting $26.88. The stock had a trading volume of 710 shares, compared to its average volume of 1,014. The company’s 50 day moving average price is $27.68 and its 200-day moving average price is $28.24. First Trust Nasdaq Pharmaceuticals ETF has a 1 year low of $25.73 and a 1 year high of $29.72. The firm has a market capitalization of $14.78 million, a P/E ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently disclosed a dividend, which was paid on Tuesday, December 31st. Investors of record on Friday, December 13th were issued a $0.1304 dividend. The ex-dividend date was Friday, December 13th. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.